Development of DNA Aptamers Against <i>Plasmodium falciparum</i> Blood Stages Using Cell-Systematic Evolution of Ligands by EXponential Enrichment.

dc.contributor.authorLantero, Elena
dc.contributor.authorBelavilas Trovas, Alexandros
dc.contributor.authorBiosca, Arnau
dc.contributor.authorRecolons, Paula
dc.contributor.authorMoles Meler, Ernest
dc.contributor.authorSulleiro, Elena
dc.contributor.authorZarzuela, Francesc
dc.contributor.authorAvalos Padilla, Yunuen
dc.contributor.authorRamírez, Miriam
dc.contributor.authorFernàndez Busquets, Xavier
dc.date.accessioned2022-04-19T12:25:10Z
dc.date.available2022-04-19T12:25:10Z
dc.date.issued2020-03-01
dc.date.updated2022-04-08T18:00:43Z
dc.description.abstract"New biomarkers have to be developed in order to increase the performance of current antigen-based malaria rapid diagnosis. Antibody production often involves the use of laboratory animals and is time-consuming and costly, especially when the target is " - ", whose variable antigen expression complicates the development of long-lived biomarkers. To circumvent these obstacles, we have applied the Systematic Evolution of Ligands by EXponential enrichment method to the rapid identification of DNA aptamers against " - "-infected red blood cells (pRBCs). Five 70 b-long ssDNA sequences, and their shorter forms without the flanking PCR primer-binding regions, have been identified having a highly specific binding of pRBCs versus non-infected erythrocytes. Structural analysis revealed G-enriched sequences compatible with the formation of G-quadruplexes. The selected aptamers recognized intracellular epitopes with apparent " - "s in the " - "M range in both fixed and non-fixed saponin-permeabilized pRBCs, improving >30-fold the pRBC detection in comparison with aptamers raised against " - " lactate dehydrogenase, the gold standard antigen for current malaria diagnostic tests. In thin blood smears of clinical samples the aptamers reported in this work specifically bound all " - " stages versus non-infected erythrocytes, and also detected early and late stages of the human malaria parasites " - ", " - " and " - . The results are discussed in the context of their potential application in future malaria diagnostic devices.
dc.format.extent20 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1550-7033
dc.identifier.pmid32493542
dc.identifier.urihttps://hdl.handle.net/2445/185018
dc.language.isoeng
dc.publisherAmerican Scientific Publishers
dc.relation.isformatofPostprint del document publicat a: http://dx.doi.org/10.1166/jbn.2020.2901
dc.relation.ispartofJournal of biomedical nanotechnology, 2020, vol. 16, num. 3, p. 315-334
dc.relation.urihttp://dx.doi.org/10.1166/jbn.2020.2901
dc.rights(c) American Scientific Publishers, 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (ISGlobal)
dc.subject.classificationMalària
dc.subject.classificationNanotecnologia
dc.subject.otherMalaria
dc.subject.otherNanotechnology
dc.titleDevelopment of DNA Aptamers Against <i>Plasmodium falciparum</i> Blood Stages Using Cell-Systematic Evolution of Ligands by EXponential Enrichment.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Lantero_E_J_Biomed_Nanotechnol_2020_Postprint.pdf
Mida:
776.57 KB
Format:
Adobe Portable Document Format